AzTrials
AzTrials

Cochlear ImplantationH2R2NCT04832373

Assessment of the Acceptability of a Humanoid Robot at Home for Children With Cochlear Implants - H2R2

A study testing Interaction with humanoid robot in people with Cochlear Implantation, run by University Hospital, Toulouse at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The quality of the rehabilitation of deafness in children with cochlear implantation is a major prognostic factor for the outcome on speech comprehension and oral expression. This rehabilitation is carried out cooperatively by the hospital cochlear implantation team, and by a speech therapist located near the child's… Read more about this study

Who is it for?
Ages 8 to 12 years
Conditions the study is for
Cochlear Implantation
What is being tested?
Interaction with humanoid robot
Could I receive a placebo?
No, everyone receives an active treatment
How many people
10 participants
Where
1 siteFrance
Study dates
17 Sep 2021to 29 Mar 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Child aged 8 to 12, user of his cochlear implant with a favorable family environment,
  • Child implanted with at least one cochlear implant undergoing speech therapy rehabilitation, and monitored by the pediatric cochlear implant unit (UPIC) of the Toulouse University Hospital
  • Child and his family whose mother tongue is French
  • Affiliation to a social security scheme

Who cannot join

  • Cognitive or psychological inability or refusal of the participant to give written consent
  • Other sensory or motor deficit that may interfere with the use of the robot
  • Unstable psychiatric pathology
  • Child with both parents benefiting from a legal protection measure

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital Toulouse - Service d'ORL, ORL pédiatrique et Otoneurologie

    Toulouse, 31059

Other trials in France

About this study

The quality of the rehabilitation of deafness in children with cochlear implantation is a major prognostic factor for the outcome on speech comprehension and oral expression. This rehabilitation is carried out cooperatively by the hospital cochlear implantation team, and by a speech therapist located near the child's home. The multi-weekly sessions represent a constraint for the child and his parents. Complementary training work at home would make it possible to balance the equity in the distribution of care in the territory, and should promote the progress of the child, who is more inclined to use a tool available at home.

Read the detailed description

The humanoid robot should allow an ecological approach to this additional rehabilitation. Before developing this approach, it is necessary to study the acceptability of the humanoid robot at home, both by the parents and by the cochlear implanted child. The main objective of this study is to assess the acceptability by the child and his family, of a humanoid robot installed at home for one month.

The secondary objectives are to describe the acceptability of the child and his family that is the relationship to technology, the intention of use, expectations, perceived utility, perception of the robot and facilitating conditions before then after 1 month of using the robot at home,

  • describe the child's acceptability with respect to his experience, his fun and the emotions felt when he uses the robot at home
Being tested
Interaction with humanoid robot
Keywords
cochlear implantation, humanoid robot

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Interaction with humanoid robotDevice

    A humanoid robot will be installed for 30 days in children. It has a touchscreen tablet, allowing manual interaction complementing the voice interaction. The robot speaks, hears, and has facial and voice identification.

Study groups in NCT04832373
Study groupRoleWhat they receive
Humanoid RobotOtherNot described
Receives: Device: Interaction with humanoid robot

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability of a humanoid robot

    assess by the number of weekly hours during which the child uses the robot.

    Measured: month 1

Secondary outcomes (8)
  1. Relationship to technology

    Assessment by a set of questionnaires and standardized scales validated by the scientific community

    Measured: month 1

  2. Intention of use

    Assessment by a set of questionnaires and standardized scales validated by the scientific community

    Measured: month 1

  3. Relationship with the robot

    Assessment by a set of questionnaires and standardized scales validated by the scientific community

    Measured: month 1

  4. User experience

    Assessment by a set of questionnaires and standardized scales validated by the scientific community

    Measured: Month 1

  5. participants' expectations

    Measurement by sentence completion which consists of giving the beginning of a sentence and letting the user complete the rest of the sentence

    Measured: Month 1

  6. 3Emethod

    Evaluation of emotions in the form of a drawing with a speech bubble and a thought bubble.

    Measured: Month 1

  7. classification of activities

    classification according to various criteria (good functioning, fun, ease of use)

    Measured: Month 1

  8. Feedback

    with a Semi-structured interview on the use of the robot

    Measured: Month 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Apr 2021
  2. Study start17 Sep 2021
  3. Primary completion29 Mar 2023
  4. Study completion29 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04832373
Sponsor's protocol ID
RC31/20/0250
Other IDs
2020-A01989-30.
Acronym
H2R2
Status last verified
Feb 2024
First submitted
31 Mar 2021
Last updated
5 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Stiti S, Caroux L, Gaillard P, Paubel PV, Deguine O. Innovative protocol of an exploratory study evaluating the acceptability of a humanoid robot at home of deaf children with cochlear implants. PLoS One. 2023 Jun 16;18(6):e0285927. doi: 10.1371/journal.pone.0285927. eCollection 2023.

    PubMed 37327230
  • Diehl JJ, Schmitt LM, Villano M, Crowell CR. The Clinical Use of Robots for Individuals with Autism Spectrum Disorders: A Critical Review. Res Autism Spectr Disord. 2012 Jan;6(1):249-262. doi: 10.1016/j.rasd.2011.05.006.

    PubMed 22125579

Questions about this trial

What is this clinical trial studying?

A study testing Interaction with humanoid robot in people with Cochlear Implantation, run by University Hospital, Toulouse at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability of a humanoid robot (time frame: month 1). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04832373, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in